Yale University: Neoplasms trials
The registry lists 14 Neoplasms studies with Yale University as lead sponsor. 5 are open to participants now and 4 have results posted.
Phase 1 4Phase 2 2No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Unified Network for Integrated Fluid Collection at YaleRecruitingNCT07689864
- Life at 100.4: An Immersive Social Virtual Reality (VR) Education Tool for Adolescent and Young Adult Cancer Patients and CaregiversRecruitingNCT07224204Not applicable
- Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer SurvivorsRecruitingNCT07019259Not applicable
- Evaluation of a Mobile App Program for Coping With CancerRecruitingNCT06923501Not applicable
- Theoretically Informed Behavioral InterventionNot yet recruitingNCT06580184Not applicable
- Feasibility of an Activity Regimen in Patients With Advanced Stage Lung CancerCompletedNCT03352245Not applicableResults posted
- Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid TumorsCompletedNCT01177007Phase 2Results posted
- Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine TumorsTerminatedNCT00730483Not applicableResults posted
- A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of MalignanciesCompletedNCT00402714Phase 2Results posted
- Nourishing Hope: The Impact of Nutrition in Cancer Treatment and Recovery in MaineActive, not recruitingNCT07076004Not applicable
- Phase I Study of the Combination of Satraplatin and Abraxane in Advanced CancersCompletedNCT00473720Phase 1
- Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy ParticipantsCompletedNCT00433485Phase 1
- Study of Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors Non-Curable With Standard TherapyTerminatedNCT00402415Phase 1
- Indium In 111 Pentetreotide in Treating Patients With Refractory CancerTerminatedNCT00002947Phase 1